Eaton Vance Management Agios Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 68,447 shares of AGIO stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,447

Previous 74,972 8.7%

Holding current value

$3.04 Million

Previous $1.66 Million 16.49%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $127,302 - $222,763	-6,525 Reduced 8.7%	68,447 $1.94 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $17 - $31	-1 Reduced -0.0%	74,972 $1.66 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $26 - $34	1 Added 0.0%	74,973 $2.18 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $32,641 - $38,416	-627 Reduced 0.83%	74,972 $4.13 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $22,424 - $29,152	507 Added 0.68%	75,599 $3.9 Million
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $861 - $1,337	-25 Reduced 0.03%	75,092 $4.02 Million
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $2,286 - $3,844	76 Added 0.1%	75,117 $3.59 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $1.91 Million - $2.92 Million	-58,879 Reduced 43.97%	75,041 $2.43 Million
Q2 2019 Aug 16, 2019	SELL	$46.17 - $68.1 $1.55 Million - $2.28 Million	-33,550 Reduced 20.03%	133,920 $6.68 Million
Q1 2019 May 14, 2019	BUY	$45.92 - $67.67 $2.33 Million - $3.43 Million	50,738 Added 43.47%	167,470 $11.3 Million
Q4 2018 Feb 07, 2019	BUY	$42.73 - $76.53 $447,981 - $802,340	10,484 Added 9.87%	116,732 $5.38 Million
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $1.47 Million - $2 Million	20,092 Added 23.32%	106,248 $8.95 Million
Q1 2018 May 07, 2018	SELL	$59.83 - $86.53 $745,780 - $1.08 Million	-12,465 Reduced 12.64%	86,156 $7.05 Million
Q4 2017 Feb 12, 2018	BUY	$52.12 - $72.33 $2.28 Million - $3.16 Million	43,741 Added 79.7%	98,621 $5.64 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $3.01 Million - $3.68 Million	54,880	54,880 $3.66 Million

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.44B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Agios Pharmaceuticals, Inc. Transaction History